District court decision invalidating claims as inherently anticipated upheld by Federal Circuit
JD Supra Law
AUGUST 7, 2023
Procedural History - United Therapeutics Corporation v. Liquidia Technologies, Inc. is an appeal and cross appeal from a District of Delaware decision that found (1) claims 1, 4, and 6–8 of U.S. Patent 10,716,793 (“the ’793 patent”) not invalid and infringed, (2) claims 1–3 of U.S. Patent 9,593,066 (“the ’066 patent”) invalid as anticipated, but otherwise infringed, (3) claims 6 and 9 of the ’066 patent invalid as anticipated and (4) claims 6, 8, and 9 of the ’066 patent as not infringed.
Let's personalize your content